India's Free Trade Agreement with New Zealand has received strong endorsement from New Zealand Prime Minister Christopher Luxon, who emphasized the deal's potential to boost exports and create opportunities for farmers and businesses. The agreement, which also provides formal recognition to India's traditional medicine system AYUSH, represents a significant milestone in bilateral trade relations.

Prime Minister's Endorsement

New Zealand Prime Minister Christopher Luxon highlighted the transformative potential of the recently finalized FTA with India. Speaking about the agreement, Luxon stated that it "will open doors for New Zealand farmers, growers, and businesses – boosting exports, creating jobs, and lifting incomes to help all Kiwis get ahead."

Describing the FTA as a "landmark deal" with the world's fastest-growing big economy, Luxon emphasized that his government has worked extremely hard to prioritize the relationship with India since day one.

AYUSH Recognition and Export Growth

The India-New Zealand FTA features dedicated provisions for traditional medicine systems, providing formal recognition to India's AYUSH sector. This recognition comes alongside robust export performance in the traditional medicine sector.

The agreement includes dedicated annexures on health-related services and traditional medicine, creating structured pathways for enhanced market access and streamlined regulatory frameworks.

Strategic Trade Context

This FTA represents India's third major trade agreement in recent months, following similar pacts with the UK and Oman. The timing is particularly significant as it provides Indian exporters with opportunities to diversify shipments in the Oceania region, especially relevant given recent global trade challenges.

Luxon described India as a "trusted partner," noting that the trade deal will deliver deep and lasting benefits for New Zealand. The agreement aims to enhance market access and promote investment flows between the two nations, positioning both countries for sustained economic growth through strengthened bilateral cooperation.

Jay Ushin Limited has announced an inter-se transfer of equity shares between its promoters, involving the gifting of 2,758 equity shares from one promoter to another. The transaction was disclosed to BSE Limited on December 29, 2025, in accordance with regulatory requirements.

Transaction Details

The share transfer involves promoter Harish Kumar Sachdeva gifting 2,758 equity shares to Smita Minda, both of whom are part of the company's promoter group. The transaction represents an inter-se transfer between promoters by way of gift.

Regulatory Compliance

The disclosure was made pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Both promoters have submitted the requisite disclosure in Form 'C' to ensure compliance with insider trading regulations.

Company Secretary Jyoti Kataria communicated the transaction details to BSE Limited, requesting the exchange to take the disclosure on record and disseminate the information further. The company has fulfilled its regulatory obligations by filing the necessary documentation within the prescribed timeframe.

Company Background

Jay Ushin Limited operates as a joint venture with Ushin Ltd. Japan and is engaged in the auto ancillaries sector. The company maintains its registered office at GI-48, G.T. Karnal Road, Industrial Area, Delhi-110033, and trades on BSE under scrip code 513252.

The inter-se transfer does not affect the overall promoter holding in the company, as the shares remain within the promoter group. Such transactions are common among promoter families and are conducted in compliance with SEBI regulations to ensure transparency in shareholding patterns.